AZN vs MRK

AstraZeneca PLC against Merck & Co. — live side-by-side technical comparison.

Prices as of 2026-11-10T21:00:02+00:00 UTC · updates daily

Who leads right now

MRK leads 5 of the 6 windows we measure — over 1 month AZN is +17.3% and MRK +1.7%; over year to date AZN is +1.6% and MRK +40.6%. The AZN/MRK price ratio stands at 1.2615, above its 50-day average of 1.1444, and below the 200-day average of 1.4302. A ratio above its own average means AZN is gaining on MRK; on this reading the recent edge belongs to AZN.

AZN/MRK over the last year

AZN/MRK price ratio · dashed: its 50- and 200-day lines · ratio above its 50-day line = AZN gaining on MRK
1.0261.3691.7122.055
Both rebased to 100 on 2025-11-10
100118.2151.1180.1AZNMRK
Ask
Compare AZN and MRK: which has been stronger over the last year, and where does each stand against its 200-day average? Ask the analyst about this pair →

Performance side by side

AZNMRK
Price$186.76 $148.05
1 day -1.4% -0.5%lead
5 days +1.6% +2.3%lead
1 month +17.3%lead +1.7%
6 months +2.1% +32.9%lead
Year to date +1.6% +40.6%lead
1 year +6.7% +70.7%lead
2 years — +43.8%
52-week position 56% of range 87% of range
52-week range $153.41–$212.71 $90.90–$156.92
vs 50-day average above $167.50 above $146.37
vs 200-day average above $180.23 above $128.05
RSI (14) 66 53
Market cap—$365.0B
Analyst target — $161.53 (+9.1%)
Analysts—26
Consensus—Buy
Next earnings Oct 30, 2026 Oct 29, 2026

Where each one stands

AZN — AstraZeneca PLC

AZN trades at $186.76, above its 50-day average of $167.50, and above the 200-day at $180.23. It sits at 56% of its 52-week range ($153.41–$212.71); 14-day RSI is 66, in neutral territory; an average session moves it about 2.7%. For levels, the first level overhead is $187.86 (0.6% away) and the first support below is $183.01 (2.0% down). On the checklist the page runs for every asset, 5 of 6 checks read bullish — the lean is bullish.

MRK — Merck & Co.

MRK trades at $148.05, above its 50-day average of $146.37, and above the 200-day at $128.05. It sits at 87% of its 52-week range ($90.90–$156.92); 14-day RSI is 53, in neutral territory; an average session moves it about 3.4%. For levels, the first level overhead is $150.00 (1.3% away) and the first support below is $146.37 (1.1% down). On the checklist the page runs for every asset, 5 of 6 checks read bullish — the lean is bullish.

Which one moves harder

MRK is the more volatile of the two — an average session moves it 3.4% against 2.7% for AZN, so an identical position size carries roughly 1.3× the daily risk.

What would change the picture

The comparison turns on those levels: AZN clearing $187.86 or losing $183.01; MRK clearing $150.00 or losing $146.37. Until one of them gives way, the relative reading above stands.

Questions people ask about AZN vs MRK

Which is performing better right now, AZN or MRK?
Over the past month AZN is +17.3% and MRK is +1.7%, so AZN is ahead on that window. Year to date the figures are +1.6% for AZN and +40.6% for MRK.
Which has done better over the last year, AZN or MRK?
Over the last year AZN is +6.7% and MRK is +70.7%, so MRK is ahead on that window.
Is AZN or MRK more volatile?
MRK is the more volatile of the two — an average session moves it 3.4% against 2.7% for AZN, so an identical position size carries roughly 1.3× the daily risk.
What are the key levels for AZN and MRK?
AZN: resistance $187.86, support $183.01; MRK: resistance $150.00, support $146.37. Levels come from recent swing zones and round numbers, recomputed daily.
When do AZN and MRK report next?
AZN: Oct 30, 2026. MRK: Oct 29, 2026. Earnings reset both the trend and the levels above, so a comparison made today is only good until the next report.
What does the AZN/MRK ratio mean?
It is simply AZN's price divided by MRK's — 1.2615 today. When the ratio rises, AZN is outperforming; when it falls, MRK is. Comparing it to its own 50- and 200-day averages shows whether the current leadership is new or long-standing.

Full technical briefs

AZN →
AstraZeneca PLC
Full technical brief: trend, levels, chart, news
MRK →
Merck & Co.
Full technical brief: trend, levels, chart, news

Related comparisons

JNJ vs LLYABBV vs LLYLLY vs MerckLLY vs UNHLLY vs NVSAZN vs LLYLLY vs TMOAMGN vs LLY